![](/img/cover-not-exists.png)
Phase I trial: CD19-Targeted CAR T-Cells in Patients with Residual CLL Following Initial Purine Analog-Based Therapy
Geyer, Mark, Park, Jae, Rivière, Isabelle, Senechal, Brigitte, Hsu, Meier, Wang, Xiuyan, Purdon, Terence, Sadelain, Michel, Brentjens, RenierVolume:
16
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2016.07.069
Date:
September, 2016
File:
PDF, 238 KB
english, 2016